HOME >> BIOLOGY >> NEWS
Research suggests diabetes drug being prescribed even when contraindicated

CHAPEL HILL Some doctors prescribe metformin, the most widely used type 2 diabetes treatment drug, for patients also suffering from congestive heart failure or kidney dysfunction or both despite clear warnings on drug packaging not to do so, a new study indicates.

The study, conducted at the University of North Carolina at Chapel Hill, showed 22 of 100 randomly selected patients on metformin had one or both of the contraindications.

Our findings are consistent with several recent studies in Europe that documented similar rates of inappropriate metformin prescribing, said Dr. Cheryl Horlen, who conducted the research as a pharmacy resident at UNC. We are concerned that these patients may be at risk of a serious medical condition known as lactic acidosis, which can be life-threatening.

In the first 14 months after its release in the United States, the Food and Drug Administration received reports of 47 confirmed cases of lactic acidosis associated with metformin, said Horlen, now an assistant professor of pharmacy practice at Campbell University. Those cases had a 42 percent mortality rate. In the absence of contraindications, the drug is considered safe and effective.

A report on the study appears as a letter in the May 15 issue of the Journal of the American Medical Association. Besides Horlen, authors are Drs. Robb Malone, Betsy Bryant, Timothy Carey, Michael Pignone and Russell Rothman of the UNC department of medicine faculty and Dr. Betty Dennis of the UNC Hospitals Pharmacy.

We performed a retrospective review of hospital charts of patients receiving metformin through the outpatient pharmacy at an academic medical center, Horlen said. We found 241 patients who had two or more prescriptions for metformin within a nine-month period and then randomly selected 100 of those for the chart review.

She and colleagues found 14 of the patients had congestive heart failure only, five had kidney dysfunction only and three
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
14-May-2002


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2018)... (PRWEB) , ... August 29, ... ... study validates first non-invasive technology to identify specific chromosomal abnormalities using morphological ... Ovation Fertility and Australia-based Life Whisperer suggests that ...
(Date:8/26/2018)... ... August 24, 2018 , ... ... laboratories. However, this technology introduces many well-described challenges around data processing, storage ... South London NHS Genomic Medicine Centre. The Viapath Genetics Laboratories have implemented ...
(Date:8/23/2018)... ... ... Mandy is an eight-year-old mini Australian shepherd and a tripod. When Mandy was four years ... surgeries to try to repair the leg and each time it was unsuccessful. Once ... along with her veterinarian, decided to amputate. With only one front leg, mobility in ...
Breaking Biology News(10 mins):
(Date:9/13/2018)... ... ... Asymmetrex’s director, James L. Sherley, M.D., Ph.D., asks audiences questions like, “How ... the means to measure the number of drug molecules in drug development research or ... holding up progress in stem cell medicine.” , “Can you imagine taking an approved ...
(Date:9/12/2018)... ... September 12, 2018 , ... NDA Partners Chairman Carl ... Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined ... Affairs and Quality Systems at WellDoc, Inc., she conducted quality control and supplier ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... disease, has been validated to be as effective as manual pathology. The study, ... in Frozen Muscle Biopsies,” was published in the Archives of Pathology & Laboratory ...
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes ... down and getting connected, too. Draper’s latest system is tiny in size, but is ... A driving factor in the new implant design is the growing awareness that disease ...
Breaking Biology Technology:
Cached News: